U.S. Markets closed
  • S&P 500

    4,482.73
    -50.03 (-1.10%)
     
  • Dow 30

    34,715.39
    -313.21 (-0.89%)
     
  • Nasdaq

    14,154.02
    -186.28 (-1.30%)
     
  • Russell 2000

    2,024.04
    -38.74 (-1.88%)
     
  • Crude Oil

    86.29
    -0.61 (-0.70%)
     
  • Gold

    1,838.90
    -3.70 (-0.20%)
     
  • Silver

    24.41
    -0.31 (-1.26%)
     
  • EUR/USD

    1.1310
    -0.0008 (-0.0679%)
     
  • 10-Yr Bond

    1.8330
    +0.0060 (+0.33%)
     
  • Vix

    25.59
    +1.74 (+7.30%)
     
  • GBP/USD

    1.3590
    -0.0010 (-0.0747%)
     
  • USD/JPY

    113.8370
    -0.2630 (-0.2305%)
     
  • BTC-USD

    41,009.23
    -835.95 (-2.00%)
     
  • CMC Crypto 200

    968.33
    -26.93 (-2.71%)
     
  • FTSE 100

    7,585.01
    -4.65 (-0.06%)
     
  • Nikkei 225

    27,158.29
    -614.61 (-2.21%)
     

A US$64m market cap addition is just what Precigen, Inc. (NASDAQ:PGEN) insiders like to see after purchasing stock worth US$3.7m

·3 min read

Insiders who bought Precigen, Inc. (NASDAQ:PGEN) stock in the last 12 months were richly rewarded last week. The company's market value increased by US$64m as a result of the stock's 8.5% gain over the same period. As a result, their original purchase of US$3.7m worth of stock is now worth US$4.0m.

Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares.

See our latest analysis for Precigen

Precigen Insider Transactions Over The Last Year

In fact, the recent purchase by Randal Kirk was the biggest purchase of Precigen shares made by an insider individual in the last twelve months, according to our records. So it's clear an insider wanted to buy, at around the current price, which is US$3.94. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. If someone buys shares at well below current prices, it's a good sign on balance, but keep in mind they may no longer see value. In this case we're pleased to report that the insider purchases were made at close to current prices.

Precigen insiders may have bought shares in the last year, but they didn't sell any. The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!

insider-trading-volume
insider-trading-volume

Precigen is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Precigen Insiders Bought Stock Recently

Over the last three months, we've seen significant insider buying at Precigen. Not only was there no selling that we can see, but they collectively bought US$3.7m worth of shares. This could be interpreted as suggesting a positive outlook.

Insider Ownership

For a common shareholder, it is worth checking how many shares are held by company insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. It appears that Precigen insiders own 10% of the company, worth about US$83m. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

What Might The Insider Transactions At Precigen Tell Us?

The recent insider purchases are heartening. We also take confidence from the longer term picture of insider transactions. But on the other hand, the company made a loss during the last year, which makes us a little cautious. When combined with notable insider ownership, these factors suggest Precigen insiders are well aligned, and that they may think the share price is too low. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. You'd be interested to know, that we found 3 warning signs for Precigen and we suggest you have a look.

Of course Precigen may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.